Fixed drug eruption and generalised erythema following etoricoxib [2]

Indian Journal of Dermatology, Venereology and Leprology

Volumn 72, Issue 4, 2006, Pages 307-309

  Augustine, Mary ^a   Sharma, Pooja ^a   Stephen, John ^a   Jayaseelan, Elizabeth ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; NIKOLSKY PHENOMENON; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; UNCLASSIFIED DRUG;

ADULT; BURSITIS; CASE REPORT; CLINICAL FEATURE; ERYTHEMA; FEMALE; FIXED DRUG ERUPTION; HUMAN; HUMAN TISSUE; LETTER; PRURITUS; RISK FACTOR; SKIN BURNING SENSATION; SKIN DEFECT; SYMPTOM;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; DRUG ERUPTIONS; ERYTHEMA; FEMALE; HUMANS; PYRIDINES; SULFONES;

EID: 33746921249     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.26732     Document Type: Letter

References (8)

1. Fitzgerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433-42.
2. Cochrane DJ, Jarvis B, Keating GM. Etoricoxib. Drugs 2002;62:2637- 51;discussion 2652-3.
3. Korkij W, Soltani K. Fixed drug eruption: A brief review. Arch Dermatol 1984;120:520-4.
4. Gupta PK, Luniya AK, Gupta NK, Tiwari ML. Coexistence of fixed drug eruptions and Stevens Johnson syndrome due to thiacetazone in a patient of pulmonary tuberculosis. Indian J Chest Dis Allied Sci 1983;25:152-4.
5. Sánchez BM, Capriles HA, Caballero FF. Adverse Reactions to Selective Cyclooxygenase-2 Inhibitors (Coxibs). Am J Ther 2004;11:494-500.
6. Fye KH, Crowley E, Berger TG, Le Boit PE, Connolly MK. Celecoxib-induced Sweet's syndrome. J Am Acad Dermatol 2001;45:300-2.
7. Schneider F, Meziani F, Chartier C, Alt M, Jaeger A. Fatal allergic vasculitis associated with celecoxib. Lancet 2002;359:852-3
8. Sarkar R, Kaur C, Kanwar AJ. Extensive fixed drug eruption to nimesulide with cross-sensitivity to sulfonamides in a child. Pediatr Dermatol 2002;19:553-4.